EUVIMEDEUVIMED entdecken
EUVIMED · CrossrefZeitschrift

Lupus Science & Medicine

ISSN 2053-8790 · BMJ

Neueste Artikel

  1. Measurement of kidney disease in a novel multidomain treatment response measure for SLE clinical trials

    Kathryn Connelly, Eric F Morand, Rachel Koelmeyer, Lavanya Rajagopala, Arushi Ramnarain, Fabien Vincent, Yanjie Hao, Ambika Wakhlu, Katie Liao, Darshini Ayton, Cassandra Gorton, Amy Somers, Brad Rovin, Dalila Tremarias, Gonzalo T Carrizo, Hermine Brunner, Jorge A Ross Terres, Joy Buie, Sandra Garces, Scott E Wenderfer, Stephen D Marks, Maria Dall’Era, Richard A Furie

    Erschienen: 2026-11DOI: 10.1136/lupus-2026-002289

  2. Lupus Nexus: developing a prospective registry, biorepository and data exchange platform to foster global collaborations, accelerate research innovation and advance precision medicine in lupus

    Teodora P Staeva, Arezou Khosroshahi, Alfred Hyoungju Kim, Devon D Kelly, Mary Jo Fekete, Kechi Anyadike, Alyssa Baloski, Shannon K Barriteau, Amonte Davis, Angela M Mitchell, Nikolay Nepochatov, Grant Roesler, Melissa Rawley-Payne, William Apruzzese, Amanda Charbonneau, Christopher Dowd, Paul R Fortin, Paul Hoover, David R Karp, Fotios Koumpouras, Martin Lewis, Meggan Mackay, Paola Mina-Osorio, Christine Peschken, Jamie Shaw, Dayani Tipple, Zahi Touma, Albert Wang, Ruth Wilson, Stacie Bell, Alison Lee, Marc S Hurlbert, Jean Stimola-Sposaro, Virginia Pascual, Inaki Sanz, Peter Schafer, S Sam Lim

    Erschienen: 2026-07DOI: 10.1136/lupus-2026-001977

  3. Maternal and neonatal outcomes in SLE: comparison of 430 pregnancies from the French GR2 study with 1720 pregnancies from French perinatal surveys

    Amandine Dernoncourt, Jean Schmidt, Gaëlle Guettrot-Imbert, Grégoire Martin De Frémont, Anne Murarasu, Marie Viaud, Camille Le Ray, Estibaliz Lazaro, Tiphaine Goulenok, Alban Deroux, Alice Berezne, Loic Raffray, Chafika Morati-Hafsaoui, Christophe Richez, Eric Hachulla, Julien Campagne, Nicolas Schleinitz, Olivier Moranne, Vincent Langlois, Odile Debouverie, Francoise Sarrot-Reynauld, Viviane Queyrel, Pauline Orquevaux, Laurent Sailler, Maddalena Larosa, Anna Molto, Véronique Le Guern, Loïc Sentilhes, Nathalie Costedoat-Chalumeau

    Erschienen: 2026-07DOI: 10.1136/lupus-2026-002300

  4. Longitudinal clinical course and long-term outcomes of SLE-associated interstitial lung disease

    Tuba Demirci Yıldırım, Berna Yurttaş, Aida Shikhaliyeva, Hasan Yardımcı, Reyhan Kose Cobanoglu, Burcu Yağız, Jehat Kılıç, Berkay Soysal, Deniz Dönmez, Derya Yildirim, Emine Sarıyıldız, Rahime Duran, Rabia Özmen, Selime Ermurat, Elif Akyazı Şener, Burak Öz, Handan Yarkan Tuğsal, Gullu Sandal Uzun, Cansu Akleylek, Gökhan Sargın, Fatma Alibaz- Oner, Yavuz Pehlivan, Figen Yargucu Zihni, Sedat Yılmaz, Ayten Yazici, Ayşe Çefle, Abdulsamet Erden, Hakan Babaoğlu, Ömer Karadağ, Ali Akdoğan, Haner Direskeneli, İsmail Sarı, Neslihan Yılmaz

    Erschienen: 2026-07DOI: 10.1136/lupus-2026-002304

  5. Real-world experience with belimumab-based triple therapy in proliferative lupus nephritis: data from the BEL-SPAIN Registry

    Paola Vidal-Montal, Aina Fabregat, Irene Altabás-González, José María Pego-Reigosa, Andrea Hernández-Martínez, Iñigo Rua-Figueroa, Tarek Salman-Monte, Clara Moriano, Beatriz Tejera Segura, Elisabet Perea, Paloma Vela, Ana Pareja-Martínez, Silvia García-Cirera, María Jesús García-Villanueva, Sandra Garrote-Corral, Sergi Heredia, Leyre Riancho-Zarrabeitia, Sara Manrique-Arija, Julia Bernárdez, Berta Magallares, Vicenç Torrente-Segarra, Beatriz Frade-Sosa, José Alfredo Gómez-Puerta, Julia Martinez-Barrio, Javier Narvaez

    Erschienen: 2026-01DOI: 10.1136/lupus-2025-001825

  6. Measurement of haemolytic anaemia in a novel treatment response measure for SLE clinical trials

    Kathryn Connelly, Eric Morand, Rachel Koelmeyer, Lavanya Rajagopala, Ambika Wakhlu, Yanjie Hao, Katie Liao, Darshini Ayton, Cassandra Gorton, Ashwini Bennett, Najha Black, Ricard Cervera, Karen Costenbader, Antonis Fanouriakis, Susanne Gydesen, Cathrine Hjelmeset, S S M Kamphuis, Zoe Karakikla-Mitsakou, Sandra Navarra, Ekemini A Ogbu, Savino Sciascia, Chris Wincup, Jinoos Yazdany, Laurie Burke, Marta Mosca, Guillermo J Pons-Estel

    Erschienen: 2026-01DOI: 10.1136/lupus-2025-001830

  7. Phase Ib, multicentre, open-label, dose-escalation study to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of subcutaneously administered mosunetuzumab in participants with systemic lupus erythematosus

    Elsa Martins, Vishala L Chindalore, X Rebecca Sheng, Aaron V Schroeder, Vivian Chen, Hardik Mody, Audrey Arjomandi, Huiyan (Ashley) Mao, Imran Hassan, Iwona Dankiewicz-Fares, Svetlana Agachi, Theodore A Omachi, Jay P Garg, William F Pendergraft

    Erschienen: 2026-01DOI: 10.1136/lupus-2026-002019

  8. Informing trial measurement in systemic lupus erythematosus: frequency of domain-specific disease activity in a multinational cohort

    Raychel Barallon, Kathryn Connelly, Vera Golder, Worawit Louthrenoo, Yi-Hsing Chen, Jiacai Cho, Aisha Lateef, Laniyati Hamijoyo, Shue-Fen Luo, Yeong-Jian Jan Wu, Sandra Navarra, Leonid Zamora, Zhanguo Li, Sargunan Sockalingam, Yasuhiro Katsumata, Masayoshi Harigai, Yanjie Hao, Zhuoli Zhang, Madelynn Chan, Jun Kikuchi, Tsutomu Takeuchi, Shereen Oon, Sang-Cheol Bae, Fiona Goldblatt, Sean O’Neill, Kristine Ng, Annie Law, BMDB Basnayake, Nicola Tugnet, Sunil Kumar, Cherica Tee, Michael Lucas Tee, Yoshiya Tanaka, Chak Sing Lau, Mandana Nikpour, Alberta Hoi, Eric Morand, Rangi Kandane-Rathnayake

    Erschienen: 2025-07DOI: 10.1136/lupus-2025-001574

Jahrgänge

2026 · 1172025 · 1622024 · 1022023 · 732022 · 962021 · 782020 · 542019 · 402018 · 482017 · 312016 · 382015 · 332014 · 31

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.